期刊文献+

PHLPP在非小细胞肺癌中的表达及临床意义

Clinicopathological correlations of PHLPP expression in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨PHLPP在非小细胞肺癌(NSCLC)中的表达及临床意义。方法采用免疫组织化学染色的方法检测82例NSCLC组织中PHLPP蛋白的表达情况,并结合临床及病理因素进行相关性分析。结果 PHLPP主要在细胞膜上表达,在NSCLC中63%阴性表达、11%为+、10%为++、16%为+++,PHLPP的表达与NSCLC的分化程度存在显著相关性(P=0.024),与年龄、性别、吸烟状况、病理类型及分期没有显著相关性。结论 PHLPP蛋白在人NSCLC组织中表达率为37%,与NSCLC的分化程度有相关性。 Objective To investigate the expression of PHLPP in non-small cell lung cancer (NSCLC)and its correla-tions of clinicopathological characteristics. Methods All of 82 tissue specimens with NSCLC were examined with im-munohistochemical staining, and the results of IHC were analyzed with the clinicopathologic characteristics. Results PHLPP mainly expressed on the cell membrane. The rate of PHLPP expression was negative in 63%, poor in 11%, moderate in 10% and strong in 16%, respectively. The expression of PHLPP was significantly correlated with differen-tiation, but not with age, smoking states, pathological type and stage. Conclusion The positive expression rate of PHLPP is 37%in human NSCLC tissue specimens and was correlated with histological differentiation .
出处 《中国现代医生》 2014年第27期21-23,F0003,共4页 China Modern Doctor
基金 浙江省医药卫生科技项目(2013KYA225) 浙江省台州市科技局项目(121KY08)
关键词 非小细胞肺癌 PHLPP 免疫组织化学 Non-small cell lung cancer(NSCLC) PHLPP Immunohistochemistry(IHC)
  • 相关文献

参考文献15

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics,2012[J]. CA Cancer J Clin, 2012,62(1 ) : 10-29.
  • 2Gao T, Furnari F, Newton AC. PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth[J]. Mol Cell, 2005,18 (1) : 13- 24.
  • 3F.L.格林尼,D.L.佩基,I.D.弗莱明,等.AJCC癌症分期手册(第6版,中文版)[M].辽宁科技出版社,第1版(2005年8月1日).
  • 4Reiner A, Neumeister B, Spona J, et al. Immunoeytochem- ical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer[J]. Cancer Res, 1990,50 (21 ) : 7057-7061.
  • 5Liu J, Weiss HL, Rychahou P, et al. loss of PHLPP ex- pression in colon cancer: role in proliferation and tumori- genesis[J]. Oncogene, 2009,28 (7) : 994-1004.
  • 6周足力,杨帆,姜冠潮,黄宇清,付静,王俊.非小细胞肺癌组织中表皮生长因子受体与磷酸化Akt蛋白的表达及其意义[J].中华医学杂志,2008,88(15):1062-1065. 被引量:3
  • 7Hu J, Liu YL, Piao SL, et al. Expression patterns of USP22 and potential targets BMI-I, PTEN, p-AKT in non -small-cell lung cancer[J]. Lung Cancer, 2012,77 (3) : 593-599.
  • 8Qiao M, Wang Y, Xu X, et al. Mstl is an interacting pro- tein that mediates PHLPPs" induced apoptosis[J]. Mol Cell, 2010,38(4) :512-523.
  • 9Liu J, Stevens PD, Gao T. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells[J]. J Biol Chem,2011,286(8) :6510-6520.
  • 10Nitsche C, Edderkaoui M, Moore RM, et al. The phos- phatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation[J]. Gas- troenterology, 2012,142 (2) : 377 -387.

二级参考文献20

  • 1Ettinger DS. Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer. Oncologist, 2006, 11:358-373.
  • 2Balsara BR, Pei J, Mitsuuehi Y, et al. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis, 2004, 25:2053-2059.
  • 3Crowell JA, Steele VE, AKT and the phosphatidylinositol 3- kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment. J Nail Cancer lnst, 2003,95:252-253.
  • 4Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol, 2003, 21:3798-3807.
  • 5Cappuzzo F, Magrini E, Ceresoli GL, et al. Akt phosphorylation and gefifinib efficacy in patients with advanced non-small-cell lung cancer. J Nail Cancer Last, 2004, 96:1133-1141.
  • 6Han SW, Hwang PG, Chung DH, et al. Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839 ) in chemotherapy-resistant non-small cell lung cancer. Int J Cancer, 2005, 113 : 109-115.
  • 7Canfley LC. The phosphoinositide 3-kinase pathway. Science, 2002, 296 : 1655-1657.
  • 8Mukohara T, Kudoh S, Yamauehi S, et al. Expression of epidermal growth factor receptor (EGFR) and downstreamactivated peptides in surgically excised non-small-cell lung cancer (NSCLC). Lung Cancer, 2003, 41:123-130.
  • 9Suzuki S, Igarashi S, Hanawa M, et al. Diversity of epidermal growth factor receptor-mediated activation of downstream molecules in human lung carcinomas. Mod Pathol, 2006, 19:986-998.
  • 10David O, Jett J, LeBeau H, et al. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res, 2004, 10:6865-6871.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部